Work

Cardiac, Vascular and Hypertension Safety of Bosutinib vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia in the BFORE Trial

Year: 2019

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.07.243

Authors: Jorge E. Cortes, Tim H. Brümmendorf, Carlo Gambacorti-Passerini, Richard Clark, Eric Leip, Andrea Viqueira, Vamsi Kota, Michael Deininger

Institutions: The University of Texas MD Anderson Cancer Center, Universitätsklinikum Aachen, RWTH Aachen University, University of Milano-Bicocca, Royal Liverpool University Hospital, Pfizer (United States), Pfizer (Spain), Augusta University, Augusta University Health, University of Utah

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2970441690

FWCI:

Cites:

Cited by:

Related to: 10